Published in J Virol on November 01, 1997
Immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proc Natl Acad Sci U S A (2000) 2.75
Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol (2005) 2.00
A G-quadruplex-containing RNA activates fluorescence in a GFP-like fluorophore. Nat Chem Biol (2014) 1.64
Engineering the quadruplex fold: nucleoside conformation determines both folding topology and molecularity in guanine quadruplexes. J Am Chem Soc (2006) 1.49
RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. Nucleic Acids Res (2004) 1.12
Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells. J Biol Chem (2008) 1.11
The intriguing prion disorders. Cell Mol Life Sci (2006) 1.09
Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins. Acc Chem Res (2010) 1.06
Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein. Nucleic Acids Res (2009) 0.99
Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotides. Nucleic Acids Res (2009) 0.97
Aptamers recognizing glycosylated hemagglutinin expressed on the surface of vaccinia virus-infected cells. Anal Chem (2010) 0.96
RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of beta-secretase BACE1 in vitro. RNA (2006) 0.94
Anti-bovine prion protein RNA aptamer containing tandem GGA repeat interacts both with recombinant bovine prion protein and its beta isoform with high affinity. Prion (2008) 0.94
Induced prion protein controls immune-activated retroviruses in the mouse spleen. PLoS One (2007) 0.91
Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell Mol Neurobiol (2006) 0.85
Heparin binding confers prion stability and impairs its aggregation. FASEB J (2014) 0.85
RNA aptamers generated against oligomeric Abeta40 recognize common amyloid aptatopes with low specificity but high sensitivity. PLoS One (2009) 0.85
Lipopolysaccharide induced conversion of recombinant prion protein. Prion (2014) 0.83
Different conformations of phosphatase and tensin homolog, deleted on chromosome 10 (PTEN) protein within the nucleus and cytoplasm of neurons. PLoS One (2011) 0.81
Screening of DNA aptamer against mouse prion protein by competitive selection. Prion (2007) 0.81
Rapid detection of natriuretic peptides by a microfluidic LabChip analyzer with DNA aptamers: Application of natriuretic peptide detection. Biomicrofluidics (2009) 0.80
Binding of recombinant but not endogenous prion protein to DNA causes DNA internalization and expression in mammalian cells. J Biol Chem (2008) 0.80
Disease-associated prion protein elicits immunoglobulin M responses in vivo. Mol Med (2006) 0.79
Interactions of prion protein with intracellular proteins: so many partners and no consequences? Cell Mol Neurobiol (2009) 0.79
DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration. PLoS One (2014) 0.78
Selection of aptamers for amyloid beta-protein, the causative agent of Alzheimer's disease. J Vis Exp (2010) 0.78
Cross-talk between prion protein and quadruplex-forming nucleic acids: a dynamic complex formation. Nucleic Acids Res (2012) 0.78
Case for an RNA-prion world: a hypothesis based on conformational diversity. J Biol Phys (2011) 0.77
Local neutral networks help maintain inaccurately replicating ribozymes. PLoS One (2014) 0.77
A visual dual-aptamer logic gate for sensitive discrimination of prion diseases-associated isoform with reusable magnetic microparticles and fluorescence quantum dots. PLoS One (2013) 0.76
Smart protein biogate as a mediator to regulate competitive host-guest interaction for sensitive ratiometric electrochemical assay of prion. Sci Rep (2015) 0.75
Melanin or melanin-like substance interacts with the N-terminal portion of prion protein and inhibits abnormal prion protein formation in prion-infected cells. J Virol (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09
Mice devoid of PrP are resistant to scrapie. Cell (1993) 11.46
Scrapie prions aggregate to form amyloid-like birefringent rods. Cell (1983) 7.92
Self-replication and scrapie. Nature (1967) 6.01
Purification and structural studies of a major scrapie prion protein. Cell (1984) 5.98
High-resolution molecular discrimination by RNA. Science (1994) 5.33
Diversity of oligonucleotide functions. Annu Rev Biochem (1995) 5.29
Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature (1996) 4.25
Does the agent of scrapie replicate without nucleic acid? Nature (1967) 4.14
Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science (1997) 3.68
N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol (1991) 3.55
A DNA aptamer that binds adenosine and ATP. Biochemistry (1995) 3.40
Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. Proc Natl Acad Sci U S A (1993) 3.35
Nucleic Acid Selection and the Challenge of Combinatorial Chemistry. Chem Rev (1997) 2.59
Prion protein gene variation among primates. J Mol Biol (1995) 2.43
A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA. Biochemistry (1993) 2.07
High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. J Immunol (1996) 2.00
Isolation and structural studies of the intact scrapie agent protein. Arch Biochem Biophys (1987) 1.97
RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. Nucleic Acids Res (1996) 1.72
Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie. Eur J Biochem (1988) 1.62
RNA aptamers that bind flavin and nicotinamide redox cofactors. J Am Chem Soc (1995) 1.41
Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci U S A (1981) 1.33
Prion protein PrPc interacts with molecular chaperones of the Hsp60 family. J Virol (1996) 1.28
The tertiary structure of a DNA aptamer which binds to and inhibits thrombin determines activity. Biochemistry (1993) 1.27
The multimerization state of retroviral RNA is modulated by ammonium ions and affects HIV-1 full-length cDNA synthesis in vitro. Nucleic Acids Res (1993) 1.17
Identification of two novel arginine binding DNAs. EMBO J (1995) 1.06
Overexpression of active Syrian golden hamster prion protein PrPc as a glutathione S-transferase fusion in heterologous systems. J Virol (1995) 1.01
In vitro selection analysis of neomycin binding RNAs with a mutagenized pool of variants of the 16S rRNA decoding region. Biochemistry (1996) 0.95
G-quartets in biology: reprise. Proc Natl Acad Sci U S A (1993) 0.93
Recombinant prion protein rPrP27-30 from Syrian golden hamster reveals proteinase K sensitivity. Biochem Biophys Res Commun (1996) 0.88
PrP27-30 is a normal soluble prion protein fragment released by human platelets. Biochem Biophys Res Commun (1996) 0.87
The major species specific epitope in prion proteins of ruminants. Arch Virol (1994) 0.86
Phytochelatins: the principal heavy-metal complexing peptides of higher plants. Science (1985) 5.75
Phytochelatins, a class of heavy-metal-binding peptides from plants, are functionally analogous to metallothioneins. Proc Natl Acad Sci U S A (1987) 4.90
Replication of polyoma DNA in isolated nuclei. I. Characterization of the system from mouse fibroblast 3T6 cells. J Mol Biol (1972) 4.47
RNA-linked short DNA fragments during polyoma replication. Proc Natl Acad Sci U S A (1973) 4.42
Phytochelatins, the heavy-metal-binding peptides of plants, are synthesized from glutathione by a specific gamma-glutamylcysteine dipeptidyl transpeptidase (phytochelatin synthase). Proc Natl Acad Sci U S A (1989) 4.31
Improvements in the phosphoramidite procedure for the synthesis of oligodeoxyribonucleotides. Nucleic Acids Res (1983) 3.36
Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev (1989) 2.82
Adenovirus DNA: structure and function of a novel replicon. Cell (1978) 2.80
Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet (1995) 2.73
A putative homologue of the human autoantigen Ku from Saccharomyces cerevisiae. J Biol Chem (1993) 2.72
Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J (1997) 2.57
Scrapie prion proteins are synthesized in neurons. Am J Pathol (1986) 2.54
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci (2000) 2.49
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
A sensitive and rapid gel retention assay for nuclear factor I and other DNA-binding proteins in crude nuclear extracts. Nucleic Acids Res (1986) 2.45
Molecular cloning of a human prion protein cDNA. DNA (1986) 2.43
Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol (1998) 2.35
Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol (1995) 2.34
Discontinuous elongation of both strands at the replication forks in polyoma DNA replication. Nat New Biol (1973) 2.20
Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature (1996) 2.20
Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. BMJ (1998) 2.15
Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology (2004) 2.15
Replication of polyoma DNA in isolated nuclei. II. Evidence for semi-conservative replication. J Mol Biol (1972) 2.10
Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology (2007) 2.09
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain (2004) 1.96
The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol (2000) 1.91
Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet (1996) 1.91
Isolation, characterization, and organ-specific expression of two novel human zinc finger genes related to the Drosophila gene spalt. Genomics (1996) 1.89
All you wanted to know about SELEX. Mol Biol Rep (1994) 1.88
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2002) 1.84
Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology (2000) 1.82
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol (2001) 1.81
Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis (1997) 1.79
Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol (1997) 1.78
Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves. J Virol (2001) 1.73
RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. Nucleic Acids Res (1996) 1.72
Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett (1997) 1.71
How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain (1999) 1.71
The NF-kappa B transcription factor induces DNA bending which is modulated by its 65-kD subunit. Nucleic Acids Res (1990) 1.69
Atypical scrapie cases in Germany and France are identified by discrepant reaction patterns in BSE rapid tests. J Virol Methods (2004) 1.68
HDF2, the second subunit of the Ku homologue from Saccharomyces cerevisiae. J Biol Chem (1996) 1.68
Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice. Mol Med (1996) 1.68
The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochim Biophys Acta (1995) 1.67
Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology (2005) 1.65
Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology (1991) 1.61
Discrimination between scrapie and bovine spongiform encephalopathy in sheep by molecular size, immunoreactivity, and glycoprofile of prion protein. J Clin Microbiol (2004) 1.60
Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain (2007) 1.56
[The Creutzfeld-Jakob disease. A sphinx of current neurobiology]. Dtsch Med Wochenschr (1997) 1.55
Molecular genetics of human prion diseases in Germany. Hum Genet (1999) 1.53
Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lancet (1993) 1.52
Involvement of the Saccharomyces cerevisiae HDF1 gene in DNA double-strand break repair and recombination. J Biol Chem (1996) 1.52
Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res (2000) 1.51
Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants. J Gen Virol (1998) 1.50
Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res (1989) 1.50
Two complementary strand-specific termination sites for adenovirus DNA replication. Cell (1976) 1.50
Isolation and DNA-binding characteristics of a protein involved in transcription activation of two divergently transcribed, essential yeast genes. EMBO J (1989) 1.50
Role of microglia in neuronal cell death in prion disease. Brain Pathol (1998) 1.49
Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol (2000) 1.49
Structural and functional organization of a porcine gene coding for nuclear factor I. Biochemistry (1989) 1.48
Push-and-pull enteroscopy using the double-balloon technique: method of assessing depth of insertion and training of the enteroscopy technique using the Erlangen Endo-Trainer. Endoscopy (2005) 1.48
Traffic-related NO2 and the prevalence of asthma and respiratory symptoms in seven year olds. Eur Respir J (1997) 1.48
Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains. Mol Med (1999) 1.47
A quantitative analysis of nuclear factor I/DNA interactions. Nucleic Acids Res (1988) 1.46
Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study. Neurology (2004) 1.45
Chemistry meets biology. Chembiochem (2001) 1.39
Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2001) 1.39
C-MYC expression in medulloblastoma and its prognostic value. Int J Cancer (2000) 1.37
The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol (1999) 1.37
Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J Gen Virol (1998) 1.36
Structural basis of ligand discrimination by two related RNA aptamers resolved by NMR spectroscopy. Science (1996) 1.36
Preferential binding of poly(A)-binding protein 1 to an inhibitory RNA element in the human immunodeficiency virus type 1 gag mRNA. J Biol Chem (1997) 1.35
Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro Oncol (2011) 1.35
Congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or Cytomegalovirus infection. Pediatrics (1997) 1.34
Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies. Acta Neuropathol (2000) 1.33
Distribution of prion protein in the ileal Peyer's patch of scrapie-free lambs and lambs naturally and experimentally exposed to the scrapie agent. J Gen Virol (2000) 1.31
Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol (1999) 1.30
Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease. EMBO J (2001) 1.29
Nuclear factor I acts as a transcription factor on the MMTV promoter but competes with steroid hormone receptors for DNA binding. EMBO J (1990) 1.29
Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study. J Med Genet (2006) 1.28
A novel RNA motif for neomycin recognition. Chem Biol (1995) 1.28
Prion protein PrPc interacts with molecular chaperones of the Hsp60 family. J Virol (1996) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. Neuroreport (1994) 1.27
Size and density of glial and neuronal cells within the cerebral neocortex of various insectivorian species. Glia (1989) 1.27
Detection of PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot. Arch Virol Suppl (2000) 1.27
Effects of copper on survival of prion protein knockout neurons and glia. J Neurochem (1998) 1.26
Synthesis of polyoma DNA by isolated nuclei. Biochem Biophys Res Commun (1971) 1.26
In vitro and in vivo characterization of novel mRNA motifs that bind special elongation factor SelB. Proc Natl Acad Sci U S A (1997) 1.26
Molecular analysis of bovine spongiform encephalopathy and scrapie strain variation. J Infect Dis (1998) 1.25
Identification of pirin, a novel highly conserved nuclear protein. J Biol Chem (1997) 1.25
Fatal familial insomnia: a new Austrian family. Brain (1999) 1.24
S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol (1997) 1.24